Swiss biomanufacturing sector continues to thrive in 2023
Strategic alliances in pharma and biotech: innovation through co-operation
Purification solutions for the large-scale production of oligonucleotide APIs
Easy mass spectrometry (MS) methods for oligonucleotide sequence confirmation and impurity detection
Innovation and the development of generic pharmaceuticals
What does it take to manufacture oligonucleotides on a large scale?
Innovative processes transforming oligonucleotide manufacturing
Cell-penetrating peptides (CPPs) as a delivery system for oligonucleotides
Bachem signs 7-year agreement with Eli Lilly to accelerate oligonucleotide production
Interview | A chat about oligonucleotides at Bachem
Evaluating the effects of ACE2-mediated COVID-19 infection
Innovative new process used to produce a diabetes and weight loss drug
Bachem celebrates 50 years
Bachem announces the launch of updated website
Bachem results reflect a successful 2014
